CAS: 28230-32-2; Hodhbt

该化合物是一种环环化合物,其特征为苯三氮结构,其中包括一个三联苯引信环,该化合物一般具有一系列化学特性,原因是存在氢氧和碳基功能组,有助于其反应和潜在的生物活动;经常研究其在药用化学中的应用,特别是其作为抗菌剂或其他治疗环境中的潜力; 氢和丙酰胺组的存在可促进氢的结合和影响各种溶剂的溶解性; 此外,该化合物可能表现出紫外线-摄氏吸收特性,从而引起对光化学研究的兴趣;其稳定性和再活性可能受到诸如pH和温度等环境因素的影响,这些因素是实验室和工业应用中的重要考虑因素.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号5623-04-1 2-氨基-N-羟基苯甲酰胺 | CAS号60941-84-6 2-oxo-1H-3,2λ4,... | CAS号134-20-3 邻氨基苯甲酸甲酯 | CAS号90-16-4 3,4-二氢-4-氧-1,2,... | CAS号28230-37-7 (4-oxo-1,2,3-be... | CAS号156881-71-9 (4-oxo-1,2,3-be... | CAS号165534-43-0 3-(二乙氧基邻酰氧基)-1,... | CAS号114119-87-8 Fm°C-Gly-ODhbt | CAS号64908-55-0 3-methoxy-1,2,3... | CAS号64908-56-1 Benzoic acid,4-... | CAS号52128-56-0 1,2,3-Benzotria...

合成工艺路线路线简述

    2-氨基-N-羟基苯甲酰胺置于盐酸,Sodium Nitrite体系中,用 水 用作溶剂,化学反应 0.5H,反应生成3-羟基-1,2,3-苯并三嗪-4(3H)-酮
    参考文献:N-羟基苯并[1,2,3]-Triazin-4(3H)-双官能膦配体使能的金(i)催化o-亲核加成反应,生成炔烃,随后[3,3]-重排:同时形成co和cn债券.
    标题:N-羟基苯并[1,2,3]-Triazin-4(3H)-双官能膦配体使能的金(i)催化o-亲核加成反应,生成炔烃,随后[3,3]-重排:同时形成co和cn债券.
    摘要:我们描述了金(i)催化串联n-羟基苯并[1,2,3]-Triazin-4(3H)-Ones与炔烃通过联苯-启用的串联o-亲核加成/ [3,3]-重排反应.具有酰胺侧基(l1)的2-基膦配体.合成了多种1-(2-氧代-2-芳基乙基)苯并[d] [1,2,3]三嗪-4(1H)-一衍生物,其收率高至优异.本协议给出了一个罕见的例子,在金(i)催化的[3,3]-σ重排中同时形成co和cn键.
    Doi:10.1021/acs.Joc.0C00471

    海关参考信息

    专利信息


    专利号:WO-9002605-A1
    优先权日:1988-09-02
    标题:An apparatus and a method for the synthesis of peptides
    发明人:MELDAL MORTEN; HOLM ARNE; BUCHARDT OLE
    权利人:MELDAL MORTEN; HOLM ARNE; BUCHARDT OLE
    摘要:An apparatus for use in chemical synthesis, especially peptide synthesis, comprises a synthesis chamber unit having a multiplicity of synthesis chambers, each of which has a liquid inlet and a liquid outlet, means for introducing liquid into the individual synthesis chambers and means for simultaneous removal of liquid via the liquid outlets of the synthesis chambers by regulation of the fluid pressure difference between the liquid inlets and the liquid outlets. A method for peptide synthesis using such an apparatus comprises the provision in each of the synthesis chambers of a solid-phase support material having a first, at least N-protected amino acid coupled thereto, after which a liquid deprotection reagent is introduced into the synthesis chambers. Following deprotection, the deprotection reagent is removed, after which a second, at least N-protected amino acid is introduced into each synthesis chamber in order to couple the first and second amino acids. Third, fourth, etc. amino acids may be coupled analogously. Complete removal of the deprotection reagent from the synthesis chambers and the support material can be ensured by incorporating a stable, intensely coloured dye, e.g., azorubin, in the deprotection reagent. The apparatus and the method make possible the parallel synthesis of a large number of peptides, e.g. peptides having overlapping amino acid sequences and constituting part of a longer peptide chain. The apparatus can be adapted to manual, semi-automatic or fully automatic performance of the various steps in the synthesis procedure.

    专利号:WO-2023030277-A1
    优先权日:2021-08-30
    标 题:Method for fully liquid-phase synthesis of grnh nonapeptide amide analog
    发明人:SUN PENGCHENG; PAN JING; WU JUNYONG; TANG YONGBO; Du Yixiong; GUO LIN
    权利人:HUNAN MICRO PEPTIDE BIOMEDICAL CO LTD
    摘要:Provided is a method for fully liquid-phase synthesis of a GRnH nonapeptide amide analog, which belongs to the technical field of medicine synthesis. The method comprises respectively synthesizing a 'Trp-Ser-Tyr' fragment, an 'R-Leu' fragment, a 'Pyr-His' fragment and 'Arg-Pro-Hunan T', wherein, R = D-Ala (alarelin), D-Leu (leuprorelin), D-Trp (deslorelin) and D-His (histrelin), and obtaining the GRnH nonapeptide amide analog with high yield and high purity by means of a '3 +2 +2 +2' fragment condensation method. The synthesis method is environmentally friendly, mild, and free of any highly toxic and poisonable reagents. The cost is greatly reduced and the synthesis method is very suitable for large-scale production.

    专利号:US-2013267680-A1
    优先权日:2010-09-15
    标题:Total chemical synthesis of ubiquitin, ubiquitin mutants and derivatives thereof
    发明人:OVAA HUIB; EL OUALID FARID; MERKX REMCO NICOLAAS SEBASTIAAN MICHEL
    权利人:OVAA HUIB; EL OUALID FARID; MERKX REMCO NICOLAAS SEBASTIAAN MICHEL; STICHTING HET NL KANKERINST
    摘要:The present invention relates to the field of total chemical synthesis of ubiquitin and related peptides. More in particular, a method is provided of solid phase synthesis of ubiquitin, ubiquitin mutants and derivatives thereof. It was the object of the present invention to provide an approach for the total chemical synthesis of ubuiqitin, which allows for the chemical synthesis of virtually any Ub mutant and giving high overall efficiency and purity. The present inventors have surprisingly found that this object can be realized with a method relying on incorporation of special amino acid building blocks. This approach was found to allow for exceptionally high yields of up to 14% and to provide an synthetic entry into virtually any ubiquitin derivative.

    专利号:WO-0100609-A1
    优先权日:1999-06-29
    标题:Method for synthesis of n-homocysteine thiolactonyl retinamide
    发明人:KAZIMIR MICHAEL; WILSON RAY E II
    权利人:UNIV BAYLOR; KAZIMIR MICHAEL; WILSON RAY E II
    摘要:The present invention describes methods of synthesis for N-homocysteine thiolactonyl retinamide (thioretinamide), a compound that has anticancer and antiatherogenic properties. The present invention further describes methods for the synthesis of N-homocysteine thiolactonyl retinamido cobalamin (thioretinaco), a compound that has potential anticancer, antineoplastic, antiviral, and antiatherogenic properties.

    专利号:WO-9707129-A1
    优先权日:1995-08-18
    标题 :Solution synthesis of peripheral acting analgesic opioid tetrapeptides
    发明人:RINALDI NICHOLAS
    权利人:IAF BIOCHEM INT; RINALDI NICHOLAS
    摘要:This invention provides a bulk scale process for the solution synthesis of enantiomerically pure peripherally acting analgesic opioid tetrapeptides corresponding to formula (I): Tyr-(D)R1-R2-R3-NH2, where R1 is Ala or Arg; R2 is Phe or Phe(p-F); and R3 is Phe or Phe(p-F). A new and unique multi-step process is disclosed comprising the joining of two dipeptides using standard solution phase synthesis techniques, but adjusting the individual factors (e.g., solvents, activating agents, neutralizing agents etc.), to minimize racemization of the second amino acid. Tremendous cost efficiencies are achieved due to elimination of traditional sequential blocking-deblocking cycles and multiple chromatographic purification steps, which also enables these simple kilogram quantity methods to be scaled up to commercial production.

    专利号:US-7288661-B2
    优先权日:2003-12-10
    标 题 :Process for the synthesis of (2S,3aS,7aS)-1-[(S)-alanyl]-octahydro-1H-indole-2-carboxylic acid compounds and application in the synthesis of perindopril
    发明人:DUBUFFET THIERRY; LECOUVE JEAN-PIERRE
    权利人:SERVIER LAB
    摘要:Process for the synthesis of compounds of formula (I): n nwherein R represents a hydrogen atom or a protecting group for the amino function.n n Application in the synthesis of perindopril and pharmaceutically acceptable salts thereof.
    上海共价化学科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.medpep.com/
    电话: 021-65566949 13901795941👤
    📞上海共价化学科技有限公司 ⚠️参考联系方式

    销售电话:021-65566949 13901795941
    邮箱:market@medpep.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    Bosque et al (2017) Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation. Cell Rep. 18 1324 PMID: 28147284

    合成参考文献


    参考文献:10.4061/2011/652702
    摘要:Crawford MJ, Rapireddy S, Bahal R, Sacui I, Ly DH. Effect of Steric Constraint at the γ-Backbone Position on the Conformations and Hybridization Properties of PNAs. J Nucleic Acids. 2011;2011():652702.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知